How should sinusitis be managed before undergoing a bone marrow transplant?

Management of Sinusitis Before Bone Marrow Transplant

All patients undergoing allogeneic bone marrow transplantation should undergo CT screening of the sinuses prior to the procedure, and any identified sinusitis should be treated with antibiotics before transplantation to reduce post-transplant infectious complications and mortality. 1

Pre-Transplant Screening Approach

Imaging All Candidates

• Obtain sinus CT scan on all patients being evaluated for allogeneic hematopoietic stem cell transplantation, regardless of symptoms 1
• Approximately 65% of pre-transplant patients are asymptomatic despite radiographic abnormalities 2
• Screening identifies occult sinus disease that poses infection risk during the profoundly immunosuppressed post-transplant period 3

Risk Stratification

Patients undergoing allogeneic transplantation face particularly high infection risk due to: 4

• Prolonged neutropenia from conditioning chemotherapy
• HLA-disparity requiring intensive immunosuppression
• Graft-versus-host disease and its treatment
• Colonization with resistant organisms (vancomycin-resistant enterococci, non-albicans Candida, Aspergillus) from prior chemotherapy courses

Treatment of Identified Sinusitis

Conservative Medical Management Preferred

Treat all symptomatic sinusitis medically before transplantation rather than pursuing surgical intervention 1

First-Line Antibiotic Therapy

• Amoxicillin remains the initial drug of choice (effective, inexpensive, well-tolerated) 4
• High-dose amoxicillin-clavulanate (90 mg/kg amoxicillin and 6.4 mg/kg clavulanate, not exceeding 2g every 12 hours) for patients not responding to amoxicillin alone 4
• Treatment duration: 10-14 days, or until symptomatically improved plus 7 additional days 4

Alternative Antibiotics

For penicillin allergy or treatment failure: 4

• Cephalosporins (cefuroxime, cefpodoxime, cefprozil, cefdinir)
• Quinolones (levofloxacin, moxifloxacin in adults)
• Avoid macrolides/erythromycins as first-line due to high S. pneumoniae resistance rates 4, 5

Monitoring Response

• Reassess at 3-5 days; if no improvement, switch to broader-spectrum coverage 4
• For persistent symptoms after 21-28 days, consider anaerobic coverage with clindamycin or metronidazole added to broad-spectrum agent 4

Adjunctive Therapies

• Nasal corticosteroids may be helpful, particularly with mucosal edema or nasal polyposis 4
• Short-term oral corticosteroids reasonable for refractory cases with marked edema, though use cautiously given upcoming immunosuppression 4

Surgical Intervention Criteria

Reserve endoscopic sinus surgery for pre-transplant patients with: 2, 3

• Symptomatic chronic rhinosinusitis with positive endoscopy AND CT findings
• Failure of appropriate medical therapy
• Structural abnormalities obstructing drainage

Critical caveat: Avoid aggressive surgical approaches based solely on radiographic changes in asymptomatic patients, as this does not predict post-transplant complications and exposes patients to unnecessary operative risk 2, 6

Post-Transplant Surveillance

High-Risk Period

• Monitor closely for sinusitis in early post-transplant period (pre-engraftment through day 100) when bacterial and fungal infections predominate 4, 1
• Maintain high index of suspicion, as clinical presentation may be subtle in immunocompromised hosts despite potentially fulminant course 3

Warning Signs Requiring Urgent Evaluation

Evaluate immediately for invasive fungal sinusitis if: 7

• Unexplained fever in neutropenic patient
• Any nasal symptoms (even minor)
• Facial pain, swelling, or erythema
• Visual changes, proptosis, or periorbital inflammation
• Neurologic signs suggesting intracranial extension

Diagnostic Approach for Suspected Post-Transplant Sinusitis

• Obtain CT imaging promptly 7, 3
• Consider diagnostic biopsy when invasive fungal infection suspected, using clinical criteria including fever, neutropenia, radiographic changes, and lack of response to antibiotics 7
• Screening nasal cultures do not reliably predict invasive aspergillosis and should not guide management 7

Treatment of Post-Transplant Sinusitis

• Invasive fungal sinusitis requires aggressive combined surgical debridement and amphotericin B therapy for survival 7
• Early diagnosis and intervention critical, as mortality approaches 57% in allogeneic recipients with delayed treatment 6

Key Pitfalls to Avoid

1. Do not skip pre-transplant CT screening even in asymptomatic patients—occult disease is common 1, 2
2. Do not perform unnecessary surgery on asymptomatic patients with radiographic-only findings, as this does not improve outcomes 2, 6
3. Do not use macrolides as first-line therapy due to resistance patterns 4, 5
4. Do not delay evaluation of post-transplant sinonasal symptoms—immunocompromised patients can deteriorate rapidly despite subtle initial presentation 3